后疫情时代新型冠状病毒感染并发症临床检验挑战与对策

Challenges and countermeasures of clinical testing of complications of conronavirus disease 2019 in the post-epidemic era

2022年12月我国进入新型冠状病毒感染后疫情时代,病毒感染及其相关并发症的大量出现对我国疫情防控和医疗资源的合理调配提出了新要求。如何在后疫情时代对新型冠状病毒感染及其并发症开展有效的指标判读及诊断,对于严峻的防控形势有着至关重要的作用。本文列举了新型冠状病毒感染及包括脓毒症、呼吸系统、循环系统、神经系统疾病在内的常见并发症的检测指标,并对其检测意义进行了解读,对目前新型检验技术和方法进行了展望,希望助力后疫情时代的新型冠状病毒感染临床检验工作。

In December 2022,China entered the post-epidemic era of the conronavirus disease 2019.The significant occurrence of virus infections and related complications has put forward new requirements for China′s epidemic prevention and control,as well as the rational allocation of medical resources.How to effectively interpret and diagnose the conronavirus disease 2019 and its complications with indicators in the post-epidemic era plays a crucial role in facing the severe prevention and control situation.This article lists the common detection indicators for complications of the conronavirus disease 2019,including sepsis,respiratory system,circulatory system,nervous system diseases,and interprets their detection significance.Also describes the new testing technologies and indicators that are expected to become more efficient,hoping to assist the clinical laboratory work of the conronavirus disease 2019 in the post-epidemic era.